For that, Nektar shoulders the blame: it developed not only the powdered insulin formulation of Exubera but also the inhaler, which was an early design. Does Exubera's flameout mean the end for ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Pfizer's data show there were six cases of lung cancer in 4,740 Exubera-treated patients versus ... the development of it and a next-generation inhaler in phase 1 trials, ceased all partnering ...

“Exubera, the first inhaled form of insulin ... According to Dr Mansouri, the inhaler was likely to hit the local market in six months. “Marketing and promotion of the product is the company ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

The world's largest drug maker, Pfizer has announced that it intends to fast track its inhaled insulin Exubera in India. The world's largest drug maker, Pfizer has announced that it intends to ...